Neumora Therapeutics nets over $500m
Neumora Therapeutics Inc, a clinical-stage biotechnology company, has raised over $500 million in funding.
Neumora Therapeutics Inc, a clinical-stage biotechnology company, has raised over $500 million in funding.
Copyright PEI Media
Not for publication, email or dissemination
